# SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])

> **NCT02401451** · NA · COMPLETED · sponsor: **Cardiocity Limited** · enrollment: 750 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** RhythmPadGP

## Key facts

- **NCT ID:** NCT02401451
- **Lead sponsor:** Cardiocity Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401451, "SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02401451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*